Dynamic Technology Lab Private LTD I Teos Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$8.57 - $11.06 $317,775 - $410,104	37,080 Added 357.19%	47,461 $520,000
Q3 2023 Nov 14, 2023	SELL	$10.95 - $14.6 $2,847 - $3,796	-260 Reduced 2.44%	10,381 $114,000
Q2 2023 Aug 14, 2023	SELL	$12.93 - $18.05 $15,709 - $21,930	-1,215 Reduced 10.25%	10,641 $141,000
Q1 2023 May 12, 2023	BUY	$13.02 - $22.62 $154,365 - $268,182	11,856 New	11,856 $161,000
Q2 2022 Aug 12, 2022	SELL	$16.57 - $35.1 $3,314 - $7,020	-200 Reduced 1.17%	16,900 $348,000
Q1 2022 May 16, 2022	BUY	$31.92 - $47.45 $545,832 - $811,395	17,100 New	17,100 $550,000

165

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $293M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.